RavenQuest Announces Dwight (Bill) Robinson Former CEO of the Alberta Gaming & Liquor Commission (“AGLC”) Joins the Team

Vancouver, British Columbia, CANADA

VANCOUVER, British Columbia, Oct. 05, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) - (CSE:RQB) is pleased to announce the appointment of Mr. Dwight "Bill" Robinson. Mr. Robinson will lead RQB efforts in Government/Indigenous Relations and Strategic Partnerships.

In this newly created and important role, Mr. Robinson's mandate will be to identify, cultivate and deepen trusting relationships with Federal and Provincial government bodies – Indigenous Peoples or otherwise - as well as to foster mutually beneficial partnerships with select Indigenous Peoples across Canada, specific to the legal production and sale of cannabis.

Over his highly rewarding 34-year career with the RCMP, Mr. Robinson served in communities across Canada, including 18 years in Alberta.  He retired as the Commanding Officer of "D" Division in Manitoba in 2012.  During this time he worked closely with many organizations and developed close and trusted working relationships with Indigenous communities. Throughout his career he has focused on social policy and harm reduction programs which have benefited many communities.

In late 2012 Mr. Robinson assumed the role of President and Chief Executive Officer of the AGLC, dedicating himself to social responsibility programs with a focus on Fetal Alcohol Spectrum Disorder.  Under his leadership AGLC was recognized as a leader in progressive gaming and liquor experiences trusted and enjoyed by Albertans through a bold and balanced approach.

Mr. Robinson holds a Master's Degree in Work Organizations and Leadership from Athabasca University, a Bachelor's Degree from Thompson Rivers University and a Certificate in Criminal Justice from the University of Virginia.  Additionally, he is a graduate of the 204th session of the F.B.I. National Academy in Quantico, Virginia and the Queen's University Executive Leadership Program.

Mr. Robinson is a member of the Order of Merit of Police Forces, a recipient of the Queen's Diamond Jubilee Medal, Governor General's Medal of Bravery, the Lieutenant Governor's Award of Merit (Alberta), the RCMP Commissioner's Commendation for Bravery, RCMP Silver Clasp and Star for long service, and two Commanding Officer's Commendations.  He has also been named as a recipient of both the Queen's Golden Jubilee and Queen's Diamond Jubilee Medals.

“We are excited to welcome Bill Robinson into RavenQuest’s management team as we further our relations with the Federal and Provincial governments and Indigenous peoples, within the cannabis sector,” stated George Robinson, RavenQuest’s CEO.

About RavenQuest Biomed Inc.

RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.

For further details on the Company readers are referred to the Company's web site (www.rqbglobal.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.

On Behalf of the Board of Directors of

"George Robinson"
Chief Executive Officer

For further information, please contact:
Mathieu McDonald, Corporate Communications

Neither Canadian Stock Exchange (“CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to the Fundamental Change and the transactions contemplated in connection therewith. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com.  Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

UNITED STATES ADVISORY.  The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), have been offered and sold outside the United States to eligible investors pursuant to Regulation S promulgated under the U.S. Securities Act, and may not be offered, sold, or resold in the United States or to, or for the account of or benefit of, a U.S. Person (as such term is defined in Regulation S under the United States Securities Act) unless the securities are registered under the U.S. Securities Act, or an exemption from the registration requirements of the U.S. Securities Act is available. Hedging transactions involving the securities must not be conducted unless in accordance with the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in the state in the United States in which such offer, solicitation or sale would be unlawful.